# Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica

> **NCT03179345** · PHASE4 · COMPLETED · sponsor: **Depomed** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Pregabalin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03179345
- **Lead sponsor:** Depomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-24
- **Primary completion:** 2015-11-20
- **Final completion:** 2015-11-20
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03179345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03179345, "Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03179345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
